Umesh Kishnani

Umesh Kishnani has a diverse work experience spanning over several companies. Umesh is currently employed at WuXi Advanced Therapies as the Executive Director of Testing Operations, a role they started in September 2022. Prior to this, they served as the Senior Director of Testing Operations at the same company from June 2021 to September 2022.

Before joining WuXi Advanced Therapies, Umesh worked at Aldevron as the Senior Director (AVP) from December 2019 to June 2021. In this role, they led a team of 68 personnel and oversaw laboratory operations for various products, including research grade, GMP-source, and GMP products. Umesh was responsible for quality control and led teams in areas such as analytical method development, method validation, QC in-process, release, environmental monitoring, and stability.

From June 2018 to December 2019, Umesh worked at Hitachi Chemical Advanced Therapeutics Solutions, LLC as the Associate Director of QC CAR-T (PPU Business Structure Head). In this role, they directed QC-analytical laboratory operations, led commercial readiness projects, and ensured compliance with regulations.

Prior to that, Umesh was employed at Regeneron Pharmaceuticals, Inc. as a Supervisor/Manager of QC Analytical Sciences from April 2017 to June 2018. Umesh supervised routine testing and coordinated resources for assay completion.

Umesh started their career at Merck in 2009, where they held multiple roles. From September 2014 to April 2017, they served as a Forced Degradation & Impurity Profiling Scientist, contributing to late-stage analytical characterization of drug substances and products. At Lancaster Laboratories for Merck & Co., Inc., they worked as a Group Lead - Protein Characterization Scientist from October 2011 to September 2014, supervising a team of scientists and providing laboratory-intensive assistance.

Umesh's early career includes roles at Merck as a Process Research Chemist II from September 2009 to September 2011 and at Roche Molecular Systems as an Associate Scientist from September 2008 to September 2009. In these positions, they conducted research, performed synthesis and purification of nucleotide sequences, and managed bioprocess HPLC machines.

Overall, Umesh Kishnani has extensive experience in laboratory operations, quality control, analytical sciences, and project management within the biopharmaceutical industry.

Umesh Kishnani pursued their undergraduate studies from 2004 to 2008 at Rutgers University, where they earned a Bachelor's of Science degree in Biomedical Engineering. Following this, they attended NYU Stern School of Business from 2015 to 2019, obtaining a Master's degree in Business Administration and Management, with a focus on General subjects.